| Symbol | SLDB |
|---|---|
| Name | SOLID BIOSCIENCES INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 500 RUTHERFORD AVENUE, THIRD FLOORCHARLESTOWN, Massachusetts, 02129, United States |
| Telephone | +1 617 337-4680 |
| Fax | — |
| — | |
| Website | https://www.solidbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001707502 |
| Description | Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy (Duchenne), SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT), AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, and additional assets for the treatment of fatal cardiac diseases. Solid is advancing its diverse pipeline across rare neuromuscular and cardiac diseases, bringing together experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted, Solids mandate is to improve the daily lives of patients living with these devastating diseases. For more information, please visit https://www.solidbio.com. Additional info from NASDAQ: |
New Form 3 - Solid Biosciences Inc. <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0001231919-26-000697 <b>Size:</b> 13 KB
Read moreNew Form SCHEDULE 13D/A - Solid Biosciences Inc. <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0001346824-26-000183 <b>Size:</b> 16 KB
Read moreNagendran Sukumar 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267504
Read moreSMITH IAN F 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267503
Read moreGanot Ilan 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267502
Read morePERCEPTIVE ADVISORS LLC 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267501
Read moreKeresty Georgia 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267500
Read moreFreed Martin I 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267499
Read moreKahn Clare 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267496
Read moreStone Adam Leo 🟢 acquired 77.5K shares (1 derivative) of Solid Biosciences Inc. (SLDB) at $6.61 Transaction Date: Jun 10, 2026 | Filing ID: 267489
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07148089 | A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Ta… | Phase1 | Catecholaminergic Polymorphic Ventricular Tachycardia | Recruiting | 2026-02-23 | 2031-05-01 | ClinicalTrials.gov |
| NCT07160634 | A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystro… | Phase3 | Duchenne Muscular Dystrophy | Recruiting | 2025-10-22 | 2034-01-01 | ClinicalTrials.gov |
| NCT07180355 | A Study of SGT-212 Gene Therapy in Friedreich's Ataxia | Phase1 | Friedreich's Ataxia (FA) | Recruiting | 2025-10-22 | 2032-02-29 | ClinicalTrials.gov |
| NCT06138639 | A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENN… | Phase1 | Duchenne Muscular Dystrophy | Recruiting | 2024-05-06 | 2031-05-06 | ClinicalTrials.gov |
| NCT05657938 | Evaluation of Home Based Assessments on Participants With DMD | — | Duchenne Muscular Dystrophy | Completed | 2022-10-13 | 2023-04-04 | ClinicalTrials.gov |
| NCT03680365 | Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families | — | Duchenne Muscular Dystrophy | Completed | 2018-09-20 | 2019-03-15 | ClinicalTrials.gov |
| NCT03368742 | Microdystrophin Gene Transfer Study in Adolescents and Children With DMD | Phase1 | Duchenne Muscular Dystrophy | Active_Not_Recruiting | 2017-12-06 | 2026-10-15 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-001 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-001 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |
| SGT-001 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| SGT-001 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| SGT-001 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| SGT-001 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| Duchenne Video Assessment (DVA) | Other | Preclinical | Duchenne Muscular Dystrophy | COMPLETED | NCT05657938 |
| Wearable Device | Device | Preclinical | Duchenne Muscular Dystrophy | COMPLETED | NCT05657938 |
| Placebo | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-003 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | RECRUITING | NCT06138639 |
| SGT-001 | Other | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-212 | Other | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| SGT-501 | Other | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-212 | DRUG | Phase PHASE1 | Friedreich's Ataxia (FA) | RECRUITING | NCT07180355 |
| Placebo | DRUG | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| SGT-501 | DRUG | Phase PHASE1 | Catecholaminergic Polymorphic Ventricular Tachycardia | RECRUITING | NCT07148089 |
| SGT-003 | DRUG | Phase PHASE3 | Duchenne Muscular Dystrophy | RECRUITING | NCT07160634 |
| Duchenne Video Assessment (DVA) | OTHER | Preclinical | Duchenne Muscular Dystrophy | COMPLETED | NCT05657938 |
| Wearable Device | DEVICE | Preclinical | Duchenne Muscular Dystrophy | COMPLETED | NCT05657938 |
| SGT-001 | GENETIC | Phase PHASE1 | Duchenne Muscular Dystrophy | ACTIVE_NOT_RECRUITING | NCT03368742 |